Paul Georges Dieulafoy
Paul Georges Dieulafoy (November 18, 1839 – August 16, 1911) was a French physician and surgeon known for his contributions to the field of medicine. He is best remembered for describing Dieulafoy's lesion, a rare but potentially life-threatening condition involving the gastrointestinal tract.
Early Life and Education[edit | edit source]
Paul Georges Dieulafoy was born in Toulouse, France. He pursued his medical studies at the University of Paris, where he earned his medical degree in 1869. During his time at the university, he was influenced by prominent physicians and surgeons, which shaped his future career.
Medical Career[edit | edit source]
Dieulafoy began his medical career as an intern at the Hôpital Necker in Paris. He later became a professor of pathology and internal medicine at the same institution. His work primarily focused on the diagnosis and treatment of gastrointestinal diseases.
Dieulafoy's Lesion[edit | edit source]
Dieulafoy's most significant contribution to medicine is the identification of Dieulafoy's lesion, also known as exulceratio simplex. This condition involves a small, abnormally large artery in the stomach wall that can cause severe gastrointestinal bleeding. Dieulafoy first described this lesion in 1898, and it has since been recognized as a critical diagnosis in patients with unexplained gastrointestinal hemorrhage.
Publications[edit | edit source]
Dieulafoy authored several influential medical texts and articles throughout his career. His works include detailed studies on gastrointestinal diseases, surgical techniques, and case reports on Dieulafoy's lesion. His publications have been widely cited and remain relevant in the field of gastroenterology.
Legacy[edit | edit source]
Paul Georges Dieulafoy's contributions to medicine, particularly in the understanding and treatment of gastrointestinal conditions, have had a lasting impact. His name is immortalized through Dieulafoy's lesion, a testament to his dedication and expertise in the field.
Related Pages[edit | edit source]
- Dieulafoy's lesion
- Gastrointestinal tract
- Gastrointestinal bleeding
- Hôpital Necker
- University of Paris
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD